{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Iratumumab",
  "nciThesaurus": {
    "casRegistry": "640735-09-7",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A fully human monoclonal antibody with potential antineoplastic activity.  MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes.  CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin disease and other lymphomas, and other cancers.",
    "fdaUniiCode": "AYH22O1B1U",
    "identifier": "C26441",
    "preferredName": "Iratumumab",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C129822",
      "C20401"
    ],
    "synonyms": [
      "IRATUMUMAB",
      "Iratumumab",
      "MDX-060",
      "Monoclonal Antibody MDX-060"
    ]
  }
}